Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: other routes

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: other route
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
other: only orientating information

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1961
Report date:
1961

Materials and methods

Principles of method if other than guideline:
according to BASF-internal standard
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium 3-nitrobenzenesulphonate
EC Number:
204-857-3
EC Name:
Sodium 3-nitrobenzenesulphonate
Cas Number:
127-68-4
Molecular formula:
C6H5NO5S.Na
IUPAC Name:
sodium 3-nitrobenzenesulphonate
Details on test material:
Name of the test substance used in the study report: Ludigol
purity: 95%

Test animals

Species:
cat
Strain:
not specified
Sex:
not specified

Administration / exposure

Route of administration:
intravenous
Vehicle:
water
Duration of treatment / exposure:
2 days
Frequency of treatment:
daily
Doses / concentrations
Remarks:
Doses / Concentrations:
2x1000 mg/kg , 1x2000 mg/kg
No. of animals per sex per dose:
2
Control animals:
no
Details on study design:
Two cats (one male, one female) were injected intravenously with a 25% or a 40% aqueous solution of the test substance on consecutive days. The animals received a dose of 1000 mg/kg b.w. twice, followed by a single dose of 2000 mg/kg b.w..

Results and discussion

Results of examinations

Details on results:
After injection of 1000 mg/kg, the animals had temporary atony; increased salivation, accelerated breathing and disturbance of equilibrium was observed in one cat. The second injection of 2000 mg/kg b.w. led to apnea for about 35 seconds, followed by atony and assumption of a lateral position. The animals recovered within 10-15 minutes. The injection sites were oedematic and lividly discolored. The hemogram revealed no pathological findings.

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion